AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Bruce Japsen
Jan. 28--Offering millions of diabetics an alternative to being stuck with a needle, the U.S. Food and Drug Administration on Friday approved a first: inhaled insulin.
The FDA approved Exubera for both type 1 and type 2 diabetes, calling the new medication-delivery option a potential alternative for "many of the more than 5 million Americans who take insulin injections." It's the first new delivery mechanism for the treatment of adult patients with diabetes since the discovery of insulin in the 1920s.
Prior to the drug's approval, "patients with diabetes who need insulin to manage their disease had only one way to treat their condition," said Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research. "It is our hope that the availability of inhaled insulin will offer patients more options to better control their…
Source: HighBeam Research, FDA OKs inhaled insulin: Alternative to injections for treating...